AMA Journal of Ethics

How should physicians researching life-sustaining technologies consider their duties to enrolled subjects?

As larger organizations become more influential in the health care sector, the Code can help physicians navigate those organizations’ influence on their practices.

Upcoding and misrepresenting clinical information constitute fraud, cost a lot, and can result in patient harm and unnecessary procedures and prescriptions.

Even disclosed conflicts of interest can be dangerous in health care settings, but disclosure might not be the panacea many seem to take it to be.

Corporatization in health care has complicated clinicians’ and organizations’ efforts to balance interests of individual patients against an organization’s bottom line.

Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective.

Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.

When responding to an ad for a job caring for patient-detainees along the US southern border, applicants should anticipate the need to navigate dual loyalties.

Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.

Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research.